Skip to main content

Table 4 CTX-HSA-NPs Mean F%

From: Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer

Time (h)

CTX-HSA-NPs (6:1)

CTX-HSA-NPs (8:1)

CTX-HSA-NPs (10:1)

0

0.00% ± 0.00%

0.00% ± 0.00%

0.00% ± 0.00%

0.5

5.32% ± 1.20%

4.67% ± 0.19%

7.43% ± 0.59%

1

11.00% ± 1.05%

11.17% ± 0.83%

12.32% ± 1.54%

2

21.97% ± 1.84%

21.01% ± 1.06%

21.28% ± 1.92%

4

42.61% ± 3.54%

41.23% ± 2.74%

35.44% ± 2.98%

6

59.76% ± 6.00%

57.17% ± 6.90%

45.61% ± 2.86%

8

78.74% ± 8.41%

67.99% ± 10.64%

54.19% ± 1.82%

10

84.63% ± 6.30%

74.23% ± 12.08%

60.50% ± 3.05%

24

97.71% ± 0.86%

93.51% ± 13.36%

81.46% ± 11.14%

30

98.13% ± 1.21%

95.77% ± 14.06%

84.25% ± 11.56%